Correction: A Comparative, Single-Blind, Randomized Study on Quetiapine and Aripiperazole Augmentation in Treatment of Selective Serotonin Reuptake Inhibitor Refractory Obsessive-Compulsive Disorder (Can. J. Physiol. Pharmacol., (2020) 98(4), (236-242), 10.1139/Cjpp-2019-0381)

Correction: A Comparative, Single-Blind, Randomized Study on Quetiapine and Aripiperazole Augmentation in Treatment of Selective Serotonin Reuptake Inhibitor Refractory Obsessive-Compulsive Disorder (Can. J. Physiol. Pharmacol., (2020) 98(4), (236-242), 10.1139/Cjpp-2019-0381) Publisher Pubmed

Talaei A^{1, 2} ; Hosseini FF^{1, 2} ; Aghili Z¹ ; Akhondzadeh S³ ; Asadpour E⁴ ; Mehramiz NJ⁵ ; Forouzanfar F^{6, 7}

Show Affiliations

1. Psychiatry and Behavioral Sciences Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
2. Department of Psychiatry, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
3. Psychiatric Research Center, Tehran University of Medical Sciences, Tehran, Iran
4. Anesthesiology and Critical Care Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
5. The University of Arizona, College of Medicine, Tucson, 85724, AZ, United States
6. Neuroscience Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
7. Department of Neuroscience, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

Source: Canadian Journal of Physiology and Pharmacology Published:2020

Abstract

On p. 236, the affiliation line for A. Talaei and F.F. Hosseini is incorrect and should read as follows: Psychiatry and Behavioral Sciences Research Center, Mashhad University of Medical Sciences, Mashhad, Iran; Department of Psychiatry, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. © 2020, Canadian Science Publishing. All rights reserved.

Style	Citing Format
MLA	Talaei A, et al.. "Correction: A Comparative, Single-Blind, Randomized Study on Quetiapine and Aripiperazole Augmentation in Treatment of Selective Serotonin Reuptake Inhibitor Refractory Obsessive-Compulsive Disorder (Can. J. Physiol. Pharmacol., (2020) 98(4), (236-242), 10.1139/Cjpp-2019-0381)." Canadian Journal of Physiology and Pharmacology, vol. 98, no. 6, 2020, pp. 412-.
APA	Talaei A, Hosseini FF, Aghili Z, Akhondzadeh S, Asadpour E, Mehramiz NJ, Forouzanfar F (2020). Correction: A Comparative, Single-Blind, Randomized Study on Quetiapine and Aripiperazole Augmentation in Treatment of Selective Serotonin Reuptake Inhibitor Refractory Obsessive-Compulsive Disorder (Can. J. Physiol. Pharmacol., (2020) 98(4), (236-242), 10.1139/Cjpp-2019-0381). Canadian Journal of Physiology and Pharmacology, 98(6), 412-.
Chicago	Talaei A, Hosseini FF, Aghili Z, Akhondzadeh S, Asadpour E, Mehramiz NJ, Forouzanfar F. "Correction: A Comparative, Single-Blind, Randomized Study on Quetiapine and Aripiperazole Augmentation in Treatment of Selective Serotonin Reuptake Inhibitor Refractory Obsessive-Compulsive Disorder (Can. J. Physiol. Pharmacol., (2020) 98(4), (236-242), 10.1139/Cjpp-2019-0381)." Canadian Journal of Physiology and Pharmacology 98, no. 6 (2020): 412-.
Harvard	Talaei A et al. (2020) 'Correction: A Comparative, Single-Blind, Randomized Study on Quetiapine and Aripiperazole Augmentation in Treatment of Selective Serotonin Reuptake Inhibitor Refractory Obsessive-Compulsive Disorder (Can. J. Physiol. Pharmacol., (2020) 98(4), (236-242), 10.1139/Cjpp-2019-0381)', Canadian Journal of Physiology and Pharmacology, 98(6), pp. 412-.
Vancouver	Talaei A, Hosseini FF, Aghili Z, Akhondzadeh S, Asadpour E, Mehramiz NJ, et al.. Correction: A Comparative, Single-Blind, Randomized Study on Quetiapine and Aripiperazole Augmentation in Treatment of Selective Serotonin Reuptake Inhibitor Refractory Obsessive-Compulsive Disorder (Can. J. Physiol. Pharmacol., (2020) 98(4), (236-242), 10.1139/Cjpp-2019-0381). Canadian Journal of Physiology and Pharmacology. 2020;98(6):412-.
BibTex	@article{ author = {Talaei A and Hosseini FF and Aghili Z and Akhondzadeh S and Asadpour E and Mehramiz NJ and Forouzanfar F}, title = {Correction: A Comparative, Single-Blind, Randomized Study on Quetiapine and Aripiperazole Augmentation in Treatment of Selective Serotonin Reuptake Inhibitor Refractory Obsessive-Compulsive Disorder (Can. J. Physiol. Pharmacol., (2020) 98(4), (236-242), 10.1139/Cjpp-2019-0381)}, journal = {Canadian Journal of Physiology and Pharmacology}, volume = {98}, number = {6}, pages = {412-}, year = {2020} }
RIS	TY - JOUR AU - Talaei A AU - Hosseini FF AU - Aghili Z AU - Akhondzadeh S AU - Asadpour E AU - Mehramiz NJ AU - Forouzanfar F TI - Correction: A Comparative, Single-Blind, Randomized Study on Quetiapine and Aripiperazole Augmentation in Treatment of Selective Serotonin Reuptake Inhibitor Refractory Obsessive-Compulsive Disorder (Can. J. Physiol. Pharmacol., (2020) 98(4), (236-242), 10.1139/Cjpp-2019-0381) JO - Canadian Journal of Physiology and Pharmacology VL - 98 IS - 6 SP - 412 EP - PY - 2020 ER -

Style

Citing Format

MLA

Talaei A, et al.. "Correction: A Comparative, Single-Blind, Randomized Study on Quetiapine and Aripiperazole Augmentation in Treatment of Selective Serotonin Reuptake Inhibitor Refractory Obsessive-Compulsive Disorder (Can. J. Physiol. Pharmacol., (2020) 98(4), (236-242), 10.1139/Cjpp-2019-0381)." Canadian Journal of Physiology and Pharmacology, vol. 98, no. 6, 2020, pp. 412-.

APA

Talaei A, Hosseini FF, Aghili Z, Akhondzadeh S, Asadpour E, Mehramiz NJ, Forouzanfar F (2020). Correction: A Comparative, Single-Blind, Randomized Study on Quetiapine and Aripiperazole Augmentation in Treatment of Selective Serotonin Reuptake Inhibitor Refractory Obsessive-Compulsive Disorder (Can. J. Physiol. Pharmacol., (2020) 98(4), (236-242), 10.1139/Cjpp-2019-0381). Canadian Journal of Physiology and Pharmacology, 98(6), 412-.

Chicago

Talaei A, Hosseini FF, Aghili Z, Akhondzadeh S, Asadpour E, Mehramiz NJ, Forouzanfar F. "Correction: A Comparative, Single-Blind, Randomized Study on Quetiapine and Aripiperazole Augmentation in Treatment of Selective Serotonin Reuptake Inhibitor Refractory Obsessive-Compulsive Disorder (Can. J. Physiol. Pharmacol., (2020) 98(4), (236-242), 10.1139/Cjpp-2019-0381)." Canadian Journal of Physiology and Pharmacology 98, no. 6 (2020): 412-.

Harvard

Talaei A et al. (2020) 'Correction: A Comparative, Single-Blind, Randomized Study on Quetiapine and Aripiperazole Augmentation in Treatment of Selective Serotonin Reuptake Inhibitor Refractory Obsessive-Compulsive Disorder (Can. J. Physiol. Pharmacol., (2020) 98(4), (236-242), 10.1139/Cjpp-2019-0381)', Canadian Journal of Physiology and Pharmacology, 98(6), pp. 412-.

Vancouver

Talaei A, Hosseini FF, Aghili Z, Akhondzadeh S, Asadpour E, Mehramiz NJ, et al.. Correction: A Comparative, Single-Blind, Randomized Study on Quetiapine and Aripiperazole Augmentation in Treatment of Selective Serotonin Reuptake Inhibitor Refractory Obsessive-Compulsive Disorder (Can. J. Physiol. Pharmacol., (2020) 98(4), (236-242), 10.1139/Cjpp-2019-0381). Canadian Journal of Physiology and Pharmacology. 2020;98(6):412-.

BibTex

@article{ author = {Talaei A and Hosseini FF and Aghili Z and Akhondzadeh S and Asadpour E and Mehramiz NJ and Forouzanfar F}, title = {Correction: A Comparative, Single-Blind, Randomized Study on Quetiapine and Aripiperazole Augmentation in Treatment of Selective Serotonin Reuptake Inhibitor Refractory Obsessive-Compulsive Disorder (Can. J. Physiol. Pharmacol., (2020) 98(4), (236-242), 10.1139/Cjpp-2019-0381)}, journal = {Canadian Journal of Physiology and Pharmacology}, volume = {98}, number = {6}, pages = {412-}, year = {2020} }

RIS

TY - JOUR
AU - Talaei A
AU - Hosseini FF
AU - Aghili Z
AU - Akhondzadeh S
AU - Asadpour E
AU - Mehramiz NJ
AU - Forouzanfar F
TI - Correction: A Comparative, Single-Blind, Randomized Study on Quetiapine and Aripiperazole Augmentation in Treatment of Selective Serotonin Reuptake Inhibitor Refractory Obsessive-Compulsive Disorder (Can. J. Physiol. Pharmacol., (2020) 98(4), (236-242), 10.1139/Cjpp-2019-0381)
JO - Canadian Journal of Physiology and Pharmacology
VL - 98
IS - 6
SP - 412
EP -
PY - 2020
ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract